Search results for "Coronavirus"
Next ACP, Annals of Internal Medicine COVID-19 forum to focus on persistent symptoms
A virtual live event on June 9 will feature a panel of experts discussing current information on treating patients with persistent symptoms following acute SARS-CoV-2 infection.
https://immattersacp.org/weekly/archives/2021/05/25/2.htm
25 May 2021
ACP, Annals of Internal Medicine host fifth forum on COVID-19
“COVID-19 Forum V: Evaluation and Care of Patients with Persistent Symptoms Following Acute SARS-CoV-2 Infection” was held on June 9.
https://immattersacp.org/weekly/archives/2021/06/15/2.htm
15 Jun 2021
Research on COVID-19 vaccines' duration, reactions, prioritization
Antibodies persisted six months after vaccination, and a graded dosing protocol allowed patients with reactions to a first shot to get a second. Surveyed Americans wanted to prioritize front-line workers and those with chronic conditions for vaccination, and a columnist finds reasons for hope.
https://immattersacp.org/weekly/archives/2021/04/13/1.htm
13 Apr 2021
New research on PASC, COVID-19 infection and vaccination during pregnancy
Two studies analyzed postacute sequelae of COVID-19 (PASC) in older and ICU patients. Other new research showed that symptomatic infection during delivery raised risks in pregnant women but vaccination during pregnancy was safe. An ACP/Annals of Internal Medicine forum focused on outpatient management of COVID-19, and the FDA issued an emergency use authorization for a new monoclonal antibody treatment.
https://immattersacp.org/weekly/archives/2022/02/15/1.htm
15 Feb 2022
New research on mixed vaccine boosters, long-term outcomes, omicron severity
A study found mixing and matching of COVID-19 vaccines to be safe and effective, other research showed ongoing symptoms to be common at one year after infection, the CDC analyzed the severity of omicron, and the FDA revised outpatient treatment authorizations.
https://immattersacp.org/weekly/archives/2022/02/01/1.htm
1 Feb 2022
Risk of re-infection, benefits of anticoagulation, cause of sex differences among COVID-19 research
Researchers published evidence of re-infection with SARS-CoV-2, anticoagulation was associated with halved inpatient mortality, recommendations were made on pulmonary embolism in COVID-19, and a study attributed differences in men's and women's outcomes to T cells.
https://immattersacp.org/weekly/archives/2020/09/01/2.htm
1 Sep 2020
Regulatory changes for COVID-19 vaccine; data on waning immunity, outpatient therapies
The FDA authorized vaccinating children, the NIH supported concurrent use of flu and COVID-19 shots, and the CDC addressed a fourth dose of COVID-19 vaccine for the immunocompromised. Trials found benefit from a new monoclonal antibody and an old antidepressant for high-risk outpatients.
https://immattersacp.org/weekly/archives/2021/11/02/1.htm
2 Nov 2021
More data on risk factors for poor COVID-19 outcomes, mixed results from treatment trials
A risk calculator, genetic findings, and red blood cell distribution width helped predict severity of and death from COVID-19. Tocilizumab showed benefit, but a number of other treatments, including CPR, did not, according to recent research.
https://immattersacp.org/weekly/archives/2020/09/29/2.htm
29 Sep 2020
New ACP resources on primary care reopening and recovery available
Resuming primary care is a key priority for supporting the U.S. health care system's capacity to manage and recover from the COVID-19 pandemic.
https://immattersacp.org/weekly/archives/2020/06/02/2.htm
2 Jun 2020
Research, news about COVID-19 vaccines, resources from ACP on flu vaccination
Results of vaccine trials were positive, but concerns arose about safety.
https://immattersacp.org/weekly/archives/2020/09/15/1.htm
15 Sep 2020